VistaPath Biosystems
Signal active
Organization
Contact Information
Overview
VistaPath Biosystems develops a tissue grossing platform that automates the process of inspecting, describing, inking, and measuring tissues that are to be processed for diagnosis.
The company's platform automatically locates, measure and image tissue as it's placed into the cassette, eliminate mix-ups and errors, visualize specimens and easily see and react to changes in workload, enabling pathologists to prepare samples for diagnosis automatically and reduce errors involved with the process.
About
Industries
Biotechnology, Health Care, Hospitality
Founded
2017
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
VistaPath Biosystems headquartered in United States, North America, operates in the Biotechnology, Health Care, Hospitality sector. The company focuses on Biotechnology and has secured $534.7M in funding across 60 round(s). With a team of 11-50 employees, VistaPath Biosystems is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - VistaPath Biosystems, raised $4.4M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
0
Lead Investors
0
Total Funding Amount
$8.9M
Details
2
VistaPath Biosystems has raised a total of $8.9M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | |||
| 2022 | Seed | 4.0M |
Investors
VistaPath Biosystems is funded by 11 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Moxxie Ventures | - | FUNDING ROUND - Moxxie Ventures | 4.0M |
| NextGen Venture Partners | - | FUNDING ROUND - NextGen Venture Partners | 4.0M |
| VistaPath Biosystems | - | FUNDING ROUND - VistaPath Biosystems | 4.0M |
| First Star Ventures | - | FUNDING ROUND - First Star Ventures | 4.0M |
Recent Activity
There is no recent news or activity for this profile.